ASP0165 Galapagos Idiopathic Pulmonary Fibrosis_Flyer_NZ_English_v1_05Oct2018
Living with idiopathic pulmonary fibrosis (IPF)?
Find out if the Isabela study is right for you.
Right now, the ISABELA clinical research study is testing a
medication in people with idiopathic pulmonary fibrosis. If you
take part in this study, you’ll receive study medication or a placebo
on top of your standard of care treatment. The study medication
is provided at no cost.
Study participants will receive:
• Study medication
• Study-related medical care
• Reimbursement for expenses
You may qualify to participate if you are:
• 40 years of age or older
• Diagnosed with pulmonary idiopathic fibrosis (IPF)
• In stable condition
Talk to your doctor or nurse about the ISABELA clinical study.
Contact Carol or Mel at 09 6385255 Ext 212 or email email@example.com